Table 2 Clinical signs and symptoms in zinc and placebo groups
From: Role of zinc in severe pneumonia: a randomized double bind placebo controlled study
Characteristics | Zinc n = 64 | Placebo n = 53 | P- value |
|---|---|---|---|
Respiratory rate at enrolment Mean (SD) | 64 (8) | 63 (11) | 0.753* |
Chest indrawing n (%) | 64 (100%) | 53 (100%) | --- |
Stridor n (%) | 6 (9.3%) | 3 (5.6%) | 0.453** |
Cyanosis n (%) | 17 (26.6%) | 9 (16.9%) | 0.215** |
Nasal flaring n (%) | 22 (34.4%) | 25 (47.2%) | 0.160** |
Wheeze n (%) | 43 (67.2%) | 40 (74.5%) | 0.326** |
Fever n (%) | 64 (100%) | 53 (100%) | --- |